16 results on '"Martínez Pascual C"'
Search Results
2. Tromboembolismo de pulmón bilateral y síndrome de Budd-Chiari en paciente con enfermedad de Crohn y toma de anticonceptivos orales
- Author
-
Valdés Mas, M., Martínez Pascual, C., Egea Valenzuela, J., Martínez Bonil, M. C., Vargas Acosta, A. M., Ortiz Sánchez, M. L., Miras López, M., and Carballo Álvarez, F.
- Subjects
Budd-Chiari syndrome ,Bilateral pulmonary thromboembolism ,congenital, hereditary, and neonatal diseases and abnormalities ,Crohn's disease ,Oral contraceptives ,Tromboembolismo de pulmón bilateral ,embryonic structures ,Anticonceptivos orales ,Enfermedad de Crohn ,Síndrome de Budd-Chiari ,nervous system diseases - Abstract
Budd-Chiari syndrome can be defined as an interruption or diminution of the normal blood flow out of the liver. Patients with Budd-Chiari syndrome present with varying degrees of symptomatology that can be divided into the following categories: fulminant, acute, subacute and chronic. The subacute form is the most common presentation. A majority of patients with Budd-Chiari syndrome have an underlying hypercoagulability state. We present the case of a young woman with Crohn's disease on oral contraceptives who developed bilateral pulmonary thromboembolism and Budd-Chiari syndrome. El síndrome de Budd-Chiari consiste en la interrupción o disminución de flujo de las venas suprahepáticas. Tiene una gran variabilidad clínica en cuanto a su forma de presentación siendo la más frecuente la forma subaguda. La gran mayoría de los pacientes responden a estados de hipercoagulabilidad. Presentamos el caso de una paciente joven con enfermedad de Crohn que estaba en tratamiento con anticonceptivos orales y desarrolló un cuadro clínico de tromboembolismo de pulmón bilateral y síndrome de Budd-Chiari.
- Published
- 2009
3. Bilateral pulmonary thromboembolism and Budd-Chiari syndrome in a patient with Crohn's disease on oral contraceptives
- Author
-
Valdés Mas, M., primary, Martínez Pascual, C., additional, Egea Valenzuela, J., additional, Martínez Bonil, M. C., additional, Vargas Acosta, A. M., additional, Ortiz Sánchez, M. L., additional, Miras López, M., additional, and Carballo Álvarez, F., additional
- Published
- 2009
- Full Text
- View/download PDF
4. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10 , 2885.
- Author
-
Chaparro M, Garre A, Núñez Ortiz A, Diz-Lois Palomares MT, Rodríguez C, Riestra S, Vela M, Benítez JM, Fernández Salgado E, Sánchez Rodríguez E, Hernández V, Ferreiro-Iglesias R, Ponferrada Díaz Á, Barrio J, Huguet JM, Sicilia B, Martín-Arranz MD, Calvet X, Ginard D, Alonso-Abreu I, Fernández-Salazar L, Varela Trastoy P, Rivero M, Vera-Mendoza I, Vega P, Navarro P, Sierra M, Cabriada JL, Aguas M, Vicente R, Navarro-Llavat M, Echarri A, Gomollón F, Guerra Del Río E, Piñero C, Casanova MJ, Spicakova K, Ortiz de Zarate J, Torrella Cortés E, Gutiérrez A, Alonso-Galán H, Hernández-Martínez Á, Marrero JM, Lorente Poyatos R, Calafat M, Martí Romero L, Robledo P, Bosch O, Jiménez N, Esteve Comas M, Duque JM, Fuentes Coronel AM, Josefa Sampedro M, Sesé Abizanda E, Herreros Martínez B, Pozzati L, Fernández Rosáenz H, Crespo Suarez B, López Serrano P, Lucendo AJ, Muñoz Vicente M, Bermejo F, Ramírez Palanca JJ, Menacho M, Carmona A, Camargo R, Torra Alsina S, Maroto N, Nerín de la Puerta J, Castro E, Marín-Jiménez I, Botella B, Sapiña A, Cruz N, Forcelledo JLF, Bouhmidi A, Castaño-Milla C, Opio V, Nicolás I, Kutz M, Abraldes Bechiarelli A, Gordillo J, Ber Y, Torres Domínguez Y, Novella Durán MT, Rodríguez Mondéjar S, Martínez-Cerezo FJ, Kolle L, Sabat M, Ledezma C, Iyo E, Roncero Ó, Irisarri R, Lluis L, Blázquez Gómez I, Zapata EM, José Alcalá M, Martínez Pascual C, Montealegre M, Mata L, Monrobel A, Hernández Camba A, Hernández L, Tejada M, Mir A, Galve ML, Soler M, Hervías D, Gómez-Valero JA, Barreiro-de Acosta M, Rodríguez-Artalejo F, García-Esquinas E, Gisbert JP, and On Behalf Of The EpidemIBD Study Group Of Geteccu
- Abstract
The authors wish to make the following corrections to this paper [...].
- Published
- 2022
- Full Text
- View/download PDF
5. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.
- Author
-
Chaparro M, Garre A, Núñez Ortiz A, Diz-Lois Palomares MT, Rodríguez C, Riestra S, Vela M, Benítez JM, Fernández Salgado E, Sánchez Rodríguez E, Hernández V, Ferreiro-Iglesias R, Ponferrada Díaz Á, Barrio J, Huguet JM, Sicilia B, Martín-Arranz MD, Calvet X, Ginard D, Alonso-Abreu I, Fernández-Salazar L, Varela Trastoy P, Rivero M, Vera-Mendoza I, Vega P, Navarro P, Sierra M, Cabriada JL, Aguas M, Vicente R, Navarro-Llavat M, Echarri A, Gomollón F, Guerra Del Río E, Piñero C, Casanova MJ, Spicakova K, Ortiz de Zarate J, Torrella Cortés E, Gutiérrez A, Alonso-Galán H, Hernández-Martínez Á, Marrero JM, Lorente Poyatos R, Calafat M, Martí Romero L, Robledo P, Bosch O, Jiménez N, Esteve Comas M, Duque JM, Fuentes Coronel AM, Josefa Sampedro M, Sesé Abizanda E, Herreros Martínez B, Pozzati L, Fernández Rosáenz H, Crespo Suarez B, López Serrano P, Lucendo AJ, Muñoz Vicente M, Bermejo F, Ramírez Palanca JJ, Menacho M, Carmona A, Camargo R, Torra Alsina S, Maroto N, Nerín de la Puerta J, Castro E, Marín-Jiménez I, Botella B, Sapiña A, Cruz N, Forcelledo JLF, Bouhmidi A, Castaño-Milla C, Opio V, Nicolás I, Kutz M, Abraldes Bechiarelli A, Gordillo J, Ber Y, Torres Domínguez Y, Novella Durán MT, Rodríguez Mondéjar S, Martínez-Cerezo FJ, Kolle L, Sabat M, Ledezma C, Iyo E, Roncero Ó, Irisarri R, Lluis L, Blázquez Gómez I, Zapata EM, José Alcalá M, Martínez Pascual C, Montealegre M, Mata L, Monrobel A, Hernández Camba A, Hernández L, Tejada M, Mir A, Galve ML, Soler M, Hervías D, Gómez-Valero JA, Barreiro-de Acosta M, Rodríguez-Artalejo F, García-Esquinas E, and Gisbert JP
- Abstract
(1) Aims: To assess the incidence of inflammatory bowel disease (IBD) in Spain, to describe the main epidemiological and clinical characteristics at diagnosis and the evolution of the disease, and to explore the use of drug treatments. (2) Methods: Prospective, population-based nationwide registry. Adult patients diagnosed with IBD-Crohn's disease (CD), ulcerative colitis (UC) or IBD unclassified (IBD-U)-during 2017 in Spain were included and were followed-up for 1 year. (3) Results: We identified 3611 incident cases of IBD diagnosed during 2017 in 108 hospitals covering over 22 million inhabitants. The overall incidence (cases/100,000 person-years) was 16 for IBD, 7.5 for CD, 8 for UC, and 0.5 for IBD-U; 53% of patients were male and median age was 43 years (interquartile range = 31-56 years). During a median 12-month follow-up, 34% of patients were treated with systemic steroids, 25% with immunomodulators, 15% with biologics and 5.6% underwent surgery. The percentage of patients under these treatments was significantly higher in CD than UC and IBD-U. Use of systemic steroids and biologics was significantly higher in hospitals with high resources. In total, 28% of patients were hospitalized (35% CD and 22% UC patients, p < 0.01). (4) Conclusion: The incidence of IBD in Spain is rather high and similar to that reported in Northern Europe. IBD patients require substantial therapeutic resources, which are greater in CD and in hospitals with high resources, and much higher than previously reported. One third of patients are hospitalized in the first year after diagnosis and a relevant proportion undergo surgery.
- Published
- 2021
- Full Text
- View/download PDF
6. Factors Influencing the Success of Peripheral Venous Access in Neonates.
- Author
-
Monasor-Ortolá D, Cortés-Castell E, Martínez-Pascual C, Esteve-Ríos A, and Rizo-Baeza MM
- Subjects
- Cross-Sectional Studies, Female, Humans, Infant, Newborn, Male, Phlebotomy, Catheterization, Central Venous, Catheterization, Peripheral, Catheters, Indwelling
- Abstract
Purpose: In neonatal units, the use of peripheral venous catheters is a commonly used technique involving risks and local complications. Catheter duration and viability is limited and may involve multiple insertion attempts. Catheterization was considered successful when there were no local complications and the catheter was removed owing to completion of treatment. The aim of the study was to determine the optimal location and instruments to reduce the number of catheter insertion attempts and to increase time without complications., Design and Methods: A cross-sectional descriptive study was undertaken to analyze all the catheters inserted in the neonatal intermediate care unit of Vinalopó University Hospital (Elche, Spain). Between 2013 and 2017 the following variables were collected: sex, age, gestational age, and venipuncture site, as well as catheter type, number of insertion attempts, duration and complications., Results: A total of 929 catheters were analyzed with a mean duration of 46.5 ± 33.9 h, and were removed upon completion of treatment (success 38.3%). The preferred site was the dorsal hand (48.2%) followed by the cubital fossa (20.1%). In both sites the success of the catheter and its duration was higher than the mean (42.4%; 43.9% and 49.4 ± 35.7; 50.3 ± 33.4 h respectively). The most frequent complications were extravasation (47.0%) and phlebitis (5.9%). Just one attempt was needed for 63.8% of cannulations of the dorsal hand, followed by 38.9% in the forearm. No significant differences were found in fixation type, sex, weight, gestational age or infusion type (continuous/intermittent)., Conclusions: The success of the technique is low. The preferred insertion sites with fewer complications, longer duration and fewer attempts were the dorsal hand and cubital fossa. With fewer attempts required for cannulation, better results were achieved on the dorsal hand., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
7. [Acquired hemophilia A in a patient with chronic hepatitis C virus infection receiving treatment with peginterferon α-2a].
- Author
-
Martínez Pascual C, Antón Ródenas G, Ortiz Sánchez ML, and Pons Miñano JA
- Subjects
- Antibodies, Monoclonal, Murine-Derived administration & dosage, Antibodies, Monoclonal, Murine-Derived therapeutic use, Antiviral Agents therapeutic use, Autoantibodies blood, Autoantibodies immunology, Autoantigens immunology, Cyclophosphamide administration & dosage, Cyclophosphamide therapeutic use, Factor VIII immunology, Glucocorticoids administration & dosage, Glucocorticoids therapeutic use, Hematoma etiology, Hemophilia A drug therapy, Hemophilia A immunology, Hepatitis C, Chronic complications, Humans, Immunosuppressive Agents therapeutic use, Interferon-alpha therapeutic use, Male, Middle Aged, Polyethylene Glycols therapeutic use, Recombinant Proteins adverse effects, Recombinant Proteins therapeutic use, Ribavirin therapeutic use, Rituximab, Antiviral Agents adverse effects, Hemophilia A chemically induced, Hepatitis C, Chronic drug therapy, Interferon-alpha adverse effects, Polyethylene Glycols adverse effects
- Published
- 2013
- Full Text
- View/download PDF
8. Beyond Heyde's syndrome.
- Author
-
Martínez-Caselles A, Martínez-Pascual C, Sánchez-Torres A, and Carballo-Álvarez F
- Subjects
- Anemia complications, Aortic Valve Stenosis complications, Aortic Valve Stenosis pathology, Blood Coagulation Disorders complications, Blood Coagulation Disorders diagnosis, Female, Gastrointestinal Hemorrhage complications, Gastrointestinal Hemorrhage pathology, Humans, Mesenteric Vascular Occlusion complications, Mesenteric Vascular Occlusion pathology, Middle Aged, Multiple Myeloma complications, Syndrome, Aortic Valve Stenosis therapy, Gastrointestinal Hemorrhage therapy
- Published
- 2012
- Full Text
- View/download PDF
9. The peritoneal macrophage inflammatory profile in cirrhosis depends on the alcoholic or hepatitis C viral etiology and is related to ERK phosphorylation.
- Author
-
Tapia-Abellán A, Martínez-Esparza M, Ruiz-Alcaraz AJ, Hernández-Caselles T, Martínez-Pascual C, Miras-López M, Such J, Francés R, and García-Peñarrubia P
- Subjects
- Ascites immunology, Ascites pathology, Cell Separation, Cytokines metabolism, Female, Hepatitis C complications, Hepatitis C immunology, Humans, Inflammation complications, Inflammation immunology, Inflammation Mediators metabolism, Leukocyte Count, Liver Cirrhosis, Alcoholic complications, Liver Cirrhosis, Alcoholic pathology, Macrophages, Peritoneal microbiology, Male, Middle Aged, Monocytes pathology, Phosphorylation, Hepatitis C enzymology, Hepatitis C virology, Inflammation pathology, Liver Cirrhosis, Alcoholic enzymology, Liver Cirrhosis, Alcoholic immunology, Macrophages, Peritoneal immunology, Macrophages, Peritoneal pathology
- Abstract
Background: The development of ascites in cirrhotic patients generally heralds a deterioration in their clinical status. A differential gene expression profile between alcohol- and hepatitis C virus (HCV)-related cirrhosis has been described from liver biopsies, especially those associated with innate immune responses. The aim of this work was to identify functional differences in the inflammatory profile of monocyte-derived macrophages from ascites in cirrhotic patients of different etiologies in an attempt to extrapolate studies from liver biopsies to immune cells in ascites. To this end 45 patients with cirrhosis and non-infected ascites, distributed according to disease etiology, HCV (n=15) or alcohol (n=30) were studied. Cytokines and the cell content in ascites were assessed by ELISA and flow cytometry, respectively. Cytokines and ERK phosphorylation in peritoneal monocyte-derived macrophages isolated and stimulated in vitro were also determined., Results: A different pattern of leukocyte migration to the peritoneal cavity and differences in the primed status of macrophages in cirrhosis were observed depending on the viral or alcoholic etiology. Whereas no differences in peripheral blood cell subpopulations could be observed, T lymphocyte, monocyte and polymorphonuclear cell populations in ascites were more abundant in the HCV than the alcohol etiology. HCV-related cirrhosis etiology was associated with a decreased inflammatory profile in ascites compared with the alcoholic etiology. Higher levels of IL-10 and lower levels of IL-6 and IL-12 were observed in ascitic fluid from the HCV group. Isolated peritoneal monocyte-derived macrophages maintained their primed status in vitro throughout the 24 h culture period. The level of ERK1/2 phosphorylation was higher in ALC peritoneal macrophages at baseline than in HCV patients, although the addition of LPS induced a greater increase in ERK1/2 phosphorylation in HCV than in ALC patients., Conclusions: The macrophage inflammatory status is higher in ascites of alcohol-related cirrhotic patients than in HCV-related patients, which could be related with differences in bacterial translocation episodes or regulatory T cell populations. These findings should contribute to identifying potential prognostic and/or therapeutic targets for chronic liver diseases of different etiology.
- Published
- 2012
- Full Text
- View/download PDF
10. Severe thrombocytopenia in liver transplantation.
- Author
-
Martínez-Pascual C, Martínez-Caselles A, Antón-Ródenas G, Carballo-Álvarez LF, and Pons-Miñano JA
- Subjects
- Female, Humans, Middle Aged, Thrombocytopenia diagnosis, Liver Transplantation, Postoperative Complications diagnosis, Thrombocytopenia etiology
- Published
- 2012
- Full Text
- View/download PDF
11. Rectal ulcer secondary to a fecal impaction due to pomegranate seed bezoar.
- Author
-
Martínez-Pascual C, Martínez-Caselles A, Antón-Ródenas G, Navarro-Noguera E, Sánchez-Torres A, García-Pérez B, and Carballo-Álvarez LF
- Subjects
- Adult, Bezoars complications, Fecal Impaction diagnosis, Humans, Lythraceae, Male, Rectal Diseases diagnosis, Ulcer diagnosis, Bezoars diagnosis, Fecal Impaction etiology, Rectal Diseases etiology, Ulcer etiology
- Published
- 2012
- Full Text
- View/download PDF
12. Tuberculous monoarthritis after treatment with adalimumab in Crohn's disease.
- Author
-
Martínez-Caselles A, Martínez-Pascual C, Muñoz-Tornero M, Sánchez-Torres A, and Carballo-Álvarez F
- Subjects
- Adalimumab, Antibodies, Monoclonal, Humanized therapeutic use, Arthritis microbiology, Arthritis, Infectious microbiology, Crohn Disease drug therapy, Humans, Immunosuppressive Agents therapeutic use, Male, Middle Aged, Mycobacterium tuberculosis, Tuberculosis, Miliary pathology, Tuberculosis, Osteoarticular microbiology, Antibodies, Monoclonal, Humanized adverse effects, Arthritis drug therapy, Arthritis, Infectious etiology, Crohn Disease complications, Immunosuppressive Agents adverse effects, Tuberculosis, Osteoarticular etiology
- Published
- 2012
- Full Text
- View/download PDF
13. Hepatoportal sclerosis clinical different evolutionary stages: presentation of 3 cases and literature review.
- Author
-
Martínez-Caselles A, Pons-Miñano JA, Vargas-Acosta Á, Ortiz-Sánchez ML, Martínez-Pascual C, Ruiz-Maciá JA, Ferri B, Ortiz-Ruiz E, and Sola J
- Subjects
- Adult, Biopsy, Humans, Hypertension, Portal pathology, Liver pathology, Liver Cirrhosis pathology, Male, Middle Aged, Pancytopenia pathology, Splenomegaly pathology, Idiopathic Noncirrhotic Portal Hypertension, Hypertension, Portal diagnosis, Liver Cirrhosis diagnosis, Pancytopenia diagnosis, Splenomegaly diagnosis
- Abstract
Hepatoportal sclerosis (HPS) is characterized by presinusoidal intrahepatic portal hypertension associated with splenomegaly and anemia in patients with non-cirrhotic liver. Liver biopsy is essential, especially to rule out other processes. Being a disease of unknown etiology, the majority of cases have been described in eastern countries. However, it may be an underdiagnosed disease in the West. Symptoms are related to portal hypertension and the clinical spectrum is wide, ranging from anemia with normal liver function tests to bleeding due to esophageal varices. Treatment is directed to the complications and the prognosis is better than in patients with cirrhosis.We report three cases of HPS presenting at different clinical stages and the findings of liver biopsies, the clinical outcomes and a review of scientific literature.
- Published
- 2012
- Full Text
- View/download PDF
14. [Fulminating hepatitis for imatinib in a patient with chronic myeloid leukaemia].
- Author
-
Martínez Pascual C, Valdés Mas M, de la Peña Moral JM, and Miras López M
- Subjects
- Adult, Antineoplastic Agents therapeutic use, Benzamides, Chemical and Drug Induced Liver Injury surgery, Female, Humans, Imatinib Mesylate, Leukemia, Myelogenous, Chronic, BCR-ABL Positive complications, Liver Failure, Acute surgery, Liver Transplantation, Piperazines therapeutic use, Protein Kinase Inhibitors therapeutic use, Pyrimidines therapeutic use, Antineoplastic Agents adverse effects, Chemical and Drug Induced Liver Injury etiology, Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy, Liver Failure, Acute chemically induced, Piperazines adverse effects, Protein Kinase Inhibitors adverse effects, Pyrimidines adverse effects
- Published
- 2011
- Full Text
- View/download PDF
15. Bilateral pulmonary thromboembolism and Budd-Chiari syndrome in a patient with Crohn s disease on oral contraceptives.
- Author
-
Valdés Mas M, Martínez Pascual C, Egea Valenzuela J, Martínez Bonil MC, Vargas Acosta AM, Ortiz Sánchez ML, Miras López M, and Carballo Alvarez F
- Subjects
- Adult, Budd-Chiari Syndrome diagnostic imaging, Colonoscopy, Crohn Disease diagnosis, Crohn Disease diagnostic imaging, Female, Heparin, Low-Molecular-Weight therapeutic use, Humans, Pulmonary Embolism diagnostic imaging, Pulmonary Embolism drug therapy, Radiography, Abdominal, Radiography, Thoracic, Tomography, X-Ray Computed, Treatment Outcome, Budd-Chiari Syndrome complications, Contraceptives, Oral adverse effects, Crohn Disease complications, Ethinyl Estradiol adverse effects, Pulmonary Embolism chemically induced
- Abstract
Budd-Chiari syndrome can be defined as an interruption or diminution of the normal blood flow out of the liver. Patients with Budd-Chiari syndrome present with varying degrees of symptomatology that can be divided into the following categories: fulminant, acute, subacute and chronic. The subacute form is the most common presentation. A majority of patients with Budd-Chiari syndrome have an underlying hypercoagulability state. We present the case of a young woman with Crohn s disease on oral contraceptives who developed bilateral pulmonary thromboembolism and Budd-Chiari syndrome.
- Published
- 2009
- Full Text
- View/download PDF
16. [Mental malaise in health professionals: an approach to its study].
- Author
-
Lomeña Villalobos JA, Martínez Pascual C, Negrillo Villalón M, and Naranjo de la Cruz A
- Subjects
- Age Factors, Health Personnel statistics & numerical data, Humans, Occupations statistics & numerical data, Prevalence, Sex Factors, Smoking epidemiology, Spain epidemiology, Surveys and Questionnaires, Health Personnel psychology, Mental Disorders epidemiology
- Abstract
A study was made of the incidence of psychiatric malaise among health workers in the health area of La Axarquía, in the province of Málaga. Goldberg's General Health Questionnaire (GHQ, 28 items) was applied to the sample population (n = 137), and the differences obtained are discussed in relation to social and job-related variables. The occurrence of psychiatric malaise among the whole sample was 29.85%, with significant differences among those above the cutoff and place of work (hospital), sex (women), tobacco habit (smokers), and pleasantness of work situation (not pleasant). There were no significant differences among those above the cutoff and profession (although higher scores were recorded among administrative personnel), nor according to contractual situation (although higher scores were recorded among contracted staff). The study concludes with a series of measures aimed at early prevention and detection of symptoms of psychiatric maladjustment within the working environment.
- Published
- 1991
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.